Herbs (Global Traditional) · African
Ficus sycomorus
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Ficus sycomorus extracts exhibit preliminary anti-inflammatory and antiparasitic properties, as demonstrated in animal models. Bioactive compounds within these extracts are hypothesized to modulate inflammatory pathways and disrupt parasitic life cycles.
Ficus sycomorus, commonly known as the sycamore fig, is a large evergreen tree native to Africa (particularly regions south of the Sahara) and parts of the Middle East, belonging to the Moraceae family. Medicinal extracts are typically obtained from dried leaves, stem bark, and fruits using methanolic, hydromethanolic, dichloromethane, or aqueous extraction methods.
All available evidence comes from preclinical animal studies with no human clinical trials identified. Key studies include anticoccidial effects in rabbits (PMID: 35743948), anti-inflammatory activity in mice, and neuroprotective effects in stressed rats (PMID: 29179735).
Animal studies used: methanolic extract at 100 mg/kg orally for 3 days (antiparasitic); DCM and methanolic extracts at 50-200 mg/kg orally (anti-inflammatory); hydromethanolic extract at 100-200 mg/kg orally (mood/cognitive effects). No human dosage data available. Consult a healthcare provider before starting any new supplement.
Ficus sycomorus (sycamore fig) nutritional and phytochemical profile is characterized by both macronutrient content in its edible fruit and a rich array of bioactive secondary metabolites across plant parts. Ripe fruits contain approximately 60-70% moisture, 1.2-2.5% crude protein, 0.3-0.8% crude fat, 18-25% total carbohydrates, and 2.5-4.5% crude dietary fiber (predominantly pectin and cellulose). Natural sugars (glucose, fructose, sucrose) account for 12-18% of fresh fruit weight. Ash content is approximately 1.0-1.8%, reflecting moderate mineral density. Micronutrient content includes calcium (40-80 mg/100g fresh weight), potassium (150-250 mg/100g), magnesium (20-45 mg/100g), phosphorus (25-50 mg/100g), iron (1.5-3.5 mg/100g), zinc (0.4-0.9 mg/100g), and manganese (0.3-0.7 mg/100g). Vitamin C content is estimated at 8-20 mg/100g fresh fruit; B-vitamins including thiamine (B1, ~0.05 mg/100g) and riboflavin (B2, ~0.04 mg/100g) are present at modest levels. Bioactive phytochemicals documented across bark, leaves, latex, and fruit include: flavonoids (rutin, quercetin, kaempferol, luteolin at combined concentrations of 5-20 mg/g dry extract), phenolic acids (gallic acid, caffeic acid, chlorogenic acid, approximately 10-30 mg/g dry extract), terpenoids (lupeol, beta-sitosterol, ursolic acid), tannins (condensed and hydrolyzable, 2-8% dry weight in bark), saponins (2-5% dry weight in leaves and bark), and alkaloids (trace levels, <1% in bark extracts). Latex contains ficin (a cysteine protease), which has bioavailability implications for protein digestion. DCM (dichloromethane) and methanolic fractions used in pharmacological studies concentrate terpenoids and flavonoids respectively. Bioavailability of polyphenols is expected to be moderate (5-15% absorption) and influenced by tannin-mineral binding, which may reduce iron and zinc bioavailability when consuming multiple plant parts simultaneously. Fiber content supports prebiotic activity. Data on fruit amino acid profile is limited but essential amino acids including lysine and threonine are present at levels typical of fig species.
The anti-inflammatory actions of Ficus sycomorus extracts are hypothesized to involve the modulation of pro-inflammatory cytokines and enzymes such as cyclooxygenase (COX) pathways. Its antiparasitic activity, observed with methanolic extracts, may stem from compounds interfering with parasite cell membrane integrity or metabolic pathways crucial for survival and reproduction, such as reducing oocyst shedding.
Preliminary animal studies investigate Ficus sycomorus's therapeutic potential. DCM and methanolic extracts (50-200 mg/kg) reduced paw edema in mice, demonstrating anti-inflammatory effects comparable to diclofenac. Additionally, a methanolic extract demonstrated antiparasitic activity in rabbits infected with Eimeria intestinalis, significantly improving growth and reducing oocyst shedding. Human clinical trials are currently lacking, limiting the applicability of these findings to human health.
Comprehensive safety data for Ficus sycomorus in humans is currently very limited, with most research confined to animal studies. Potential side effects, specific drug interactions, or contraindications have not been thoroughly evaluated. Due to a lack of human studies, its safety during pregnancy and lactation is unknown, and use should be avoided. Consultation with a healthcare professional is advised before use.
